Ronald I. Meltzer
Direktor/Vorstandsmitglied bei Sequella, Inc.
Profil
Ronald I.
Meltzer is currently a Director at Sequella, Inc. and a Member-Washington Leadership Board at State University of New York at Buffalo Law School.
He formerly worked as a Principal at American University and as a Professor at State University of New York at Buffalo.
He holds a doctorate degree from The Trustees of Columbia University in The City of New York, a graduate degree from New York University, and an undergraduate degree from The Ohio University.
Aktive Positionen von Ronald I. Meltzer
Unternehmen | Position | Beginn |
---|---|---|
Sequella, Inc.
Sequella, Inc. Pharmaceuticals: MajorHealth Technology Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD. | Direktor/Vorstandsmitglied | - |
State University of New York at Buffalo Law School | Corporate Officer/Principal | 20.07.2011 |
Ehemalige bekannte Positionen von Ronald I. Meltzer
Unternehmen | Position | Ende |
---|---|---|
American University | Corporate Officer/Principal | - |
State University of New York at Buffalo | Corporate Officer/Principal | - |
Ausbildung von Ronald I. Meltzer
New York University | Graduate Degree |
The Trustees of Columbia University in The City of New York | Doctorate Degree |
The Ohio University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Sequella, Inc.
Sequella, Inc. Pharmaceuticals: MajorHealth Technology Sequella, Inc. develops antibiotic drugs resistant to bacterial, fungal, and parasitic infections. It offers product for Mycobacterium tuberculosis, Helicobacter pylori, Clostridium difficile, Nontuberculous mycobacteria, Trypanosomes, and fungal infections. The company was founded by Carol A. Nacy and Leo Einck in 1997 and is headquartered in Rockville, MD. | Health Technology |